TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Chemotechnique Mb Diagnostics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
6,393
|
6,168
|
5,125 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
1,675
|
1,735
|
1,374 |
| EBITDA |
1,715
|
1,800
|
1,495 |
| Total assets |
5,083
|
5,317
|
4,607 |
| Current assets |
4,862
|
5,042
|
4,239 |
| Current liabilities |
847
|
1,554
|
1,437 |
| Equity capital |
4,210
|
3,732
|
3,088 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
37
|
35
|
32 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
82.8%
|
70.2%
|
67.0% |
| Turnover per employee |
173
|
176
|
160 |
| Profit as a percentage of turnover |
26.2%
|
28.1%
|
26.8% |
| Return on assets (ROA) |
33.0%
|
32.6%
|
29.8% |
| Current ratio |
574.0%
|
324.5%
|
295.0% |
| Return on equity (ROE) |
39.8%
|
46.5%
|
44.5% |
| Change turnover |
434
|
1,028
|
446 |
| Change turnover % |
7%
|
20%
|
10% |
| Chg. No. of employees |
2
|
3
|
2 |
| Chg. No. of employees % |
6%
|
9%
|
7% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.